TargetTrack | Target Query Results

1 targets match your request

Target ID:JCSG-419275
Source Organism
Bacteroides caccae atcc 43185
Target Name
SP16569C
Target Category
structural coverage,community nominated,structural coverage,biomedical,biomedical,disease,disease,community nominated
Target Rationale
Inhibitors of sialidases present potential therapeutic value. The ultimate goal is to create and optimize a microbiota-targeted sialidase-inhibitor toolkit by molecular screening and structural biology.
Status
in PDB
Site
JCSG
Site ID
419275
Lab List
GNF,SSRL,UCSD
Clone available
BcCD00546273
Structure available
4q6k
Remark
Putative neuraminidase, N-terminal domain of BNR-repeat neuraminidase (PF14873), BNR repeat-like domain (PF13088)
URL
http://www1.jcsg.org/...
Last Update
2016-03-31
Project List
PSI-2, PSI-3
Database References
NCBI RefSeq: ZP_01959484.1, PSICNT: 228


Targets that contain a matching or similar sequence to your query are listed with the best alignments presented at the top. View the Alignment tab to see how closely a target sequence matches your query.

A target containing one or more sequences may have multiple alignments in this tab.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.